+ Watch PDII
on My Watchlist
A sales and marketing services company, which serves the biopharmaceutical and life sciences industries.
Trading below book value, new management. Their price was beaten down for loss of a large contract, but they've since picked up another. Not profitable at the moment, but with the company trading below book value your risks are pretty low. With the new sales director this stock can only get better.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions